{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:27:32Z","timestamp":1782865652286,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bleeding anomalies have been reported in patients affected by Noonan syndrome. No study has been performed in patients with molecularly confirmed RASopathy. We aimed to characterize the frequency and types of bleeding disorders in patients with RASopathies and evaluate any significant association with laboratory findings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and methods<\/jats:title>\n                <jats:p>Forty-nine individuals (<jats:italic>PTPN11<\/jats:italic>, n\u2009=\u200927; <jats:italic>SOS1<\/jats:italic>, n\u2009=\u20097; <jats:italic>RIT1<\/jats:italic>, n\u2009=\u20093; <jats:italic>SPRED1<\/jats:italic>, n\u2009=\u20091; <jats:italic>LZTR1<\/jats:italic>, N\u2009=\u20093; <jats:italic>RAF1<\/jats:italic>, n\u2009=\u20092; <jats:italic>BRAF<\/jats:italic>, n\u2009=\u20094; <jats:italic>MEK1<\/jats:italic>, n\u2009=\u20091; <jats:italic>MEK2<\/jats:italic>, n\u2009=\u20091), and 49 age- and sex-matched controls were enrolled. The \u201cPaediatric Bleeding Questionnaire Scoring Key\u201d was administered to patients and families. Laboratory screening tests including clotting factors dosing, platelet count, Prothrombin Time and\u00a0Partial Thromboplastin Time, were employed both in patients and controls to characterize the bleeding diathesis. A subgroup of 29\/49 patients and 29\/49 controls was also tested for platelet function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Regardless of the gene involved, pathological paediatric bleeding scores were recorded in 14\/49 (28.5%) patients. Indeed, 7 were mutated in <jats:italic>PTPN11<\/jats:italic>, 3 in <jats:italic>SOS1<\/jats:italic>, 2 in <jats:italic>RIT1<\/jats:italic>, 1 in <jats:italic>BRAF<\/jats:italic>, and 1 in <jats:italic>MEK1<\/jats:italic>. Compared to patients with normal bleeding scores, those with pathologic bleeding score showed higher prevalence of splenomegaly (<jats:italic>p<\/jats:italic>\u2009=\u20090.006), prolonged aPTT (<jats:italic>p<\/jats:italic>\u2009=\u20090.04), lower levels of coagulation factor V (FV, <jats:italic>p<\/jats:italic>\u2009=\u20090.001), FVII (<jats:italic>p<\/jats:italic>\u2009=\u20090.003), FX (<jats:italic>p<\/jats:italic>\u2009=\u20090.0008) and FXIII (<jats:italic>p<\/jats:italic>\u2009=\u20090.002), higher vWAg (<jats:italic>p<\/jats:italic>\u2009=\u20090.04), and lower platelet sensitivity to Ristocetin (<jats:italic>p<\/jats:italic>\u2009=\u20090.001), arachidonic acid (AA) (<jats:italic>p<\/jats:italic>\u2009=\u20090.009) and collagen (<jats:italic>p<\/jats:italic>\u2009=\u20090.01). The presence of hematomas inversely correlated with factor V (<jats:italic>p<\/jats:italic>\u2009=\u20090.002), factor VII (<jats:italic>p<\/jats:italic>\u2009=\u20090.003), factor X (<jats:italic>p<\/jats:italic>\u2009=\u20090.002) and factor XIII (<jats:italic>p<\/jats:italic>\u2009=\u20090.004) levels, and directly correlated with platelet response to collagen (<jats:italic>p<\/jats:italic>\u2009=\u20090.02) and AA (<jats:italic>p<\/jats:italic>\u2009=\u20090.01). The presence of splenomegaly directly correlated with the presence of hematoma (<jats:italic>p<\/jats:italic>\u2009=\u20090.006), platelet response to Ristocetin (<jats:italic>p<\/jats:italic>\u2009=\u20090.04) and AA (<jats:italic>p<\/jats:italic>\u2009=\u20090.04), and inversely correlated with factor V levels (<jats:italic>p<\/jats:italic>\u2009=\u20090.03).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients with RASopathies and a bleeding tendency exhibit multiple laboratory abnormalities, including platelet-related disorders. Splenomegaly is frequently detected and might be a suggestive sign for qualitative platelet dysfunction. A comprehensive clinical assessment should be carried out at diagnosis, during the follow-up and before any surgical procedures. Since there is currently no consensus on management of bleeding complications, it is important that physicians closely monitor these patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-02122-7","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T12:03:30Z","timestamp":1638446610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["RASopathies and hemostatic abnormalities: key role of platelet dysfunction"],"prefix":"10.1186","volume":"16","author":[{"given":"Francesca","family":"Di Candia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Anna","family":"Siano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariateresa","family":"Falco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Assunto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Boccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Magliacane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Strisciuglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9458-3926","authenticated-orcid":false,"given":"Daniela","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"issue":"5","key":"2122_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1210\/er.2017-00232","volume":"39","author":"M Tajan","year":"2018","unstructured":"Tajan M, Paccoud R, Branka S, Edouard T, Yart A. The RASopathy family: consequences of germline activation of the RAS\/MAPK pathway. Endocr Rev. 2018;39(5):676\u2013700.","journal-title":"Endocr Rev"},{"issue":"1","key":"2122_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.beem.2010.09.002","volume":"25","author":"M Tartaglia","year":"2011","unstructured":"Tartaglia M, Gelb BD, Zenker M. Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab. 2011;25(1):161\u201379.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"2122_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000276766","volume":"1","author":"M Tartaglia","year":"2010","unstructured":"Tartaglia M, Zampino G, Gelb BD. Noonan syndrome: clinical aspects and molecular pathogenesis. Mol Syndromol. 2010;1(1):2\u201326.","journal-title":"Mol Syndromol"},{"issue":"11","key":"2122_CR4","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1136\/jmg.2004.021451","volume":"41","author":"B Keren","year":"2004","unstructured":"Keren B, Hadchouel A, Saba S, Sznajer Y, Bonneau D, Leheup B, et al. PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience. J Med Genet. 2004;41(11):e117.","journal-title":"J Med Genet"},{"issue":"4","key":"2122_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng772","volume":"29","author":"M Tartaglia","year":"2001","unstructured":"Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29(4):465\u20138. Erratum in: Nat Genet 2001;29(4):491. Erratum in: Nat Genet 2002;30(1):123.","journal-title":"Nat Genet"},{"issue":"2","key":"2122_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1086\/499925","volume":"78","author":"M Tartaglia","year":"2006","unstructured":"Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, et al. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet. 2006;78(2):279\u201390.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2122_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ajhg.2020.06.018","volume":"107","author":"M Motta","year":"2020","unstructured":"Motta M, Pannone L, Pantaleoni F, Bocchinfuso G, Radio FC, Cecchetti S, et al. Enhanced MAPK1 function causes a neurodevelopmental disorder within the RASopathy clinical spectrum. Am J Hum Genet. 2020;107(3):499\u2013513.","journal-title":"Am J Hum Genet"},{"key":"2122_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/JBM.S164474","volume":"9","author":"DJ Nugent","year":"2018","unstructured":"Nugent DJ, Romano AA, Sabharwal S, Cooper DL. Evaluation of bleeding disorders in patients with Noonan syndrome: a systematic review. J Blood Med. 2018;9:185\u201392.","journal-title":"J Blood Med"},{"issue":"10","key":"2122_CR9","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1440-1746.2004.02931.x","volume":"19","author":"SN Sgouros","year":"2004","unstructured":"Sgouros SN, Karamanolis G, Papadopoulou E, Papageorgiou G, Stefanides G, Nastos H, et al. Post biopsy intramural hematoma of the duodenum in an adult with Noonan\u2019s syndrome. J Gastroenterol Hepatol. 2004;19(10):1217\u20139.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"2122_CR10","doi-asserted-by":"publisher","first-page":"e1299","DOI":"10.1542\/peds.2013-3251","volume":"133","author":"A Artoni","year":"2014","unstructured":"Artoni A, Selicorni A, Passamonti SM, Lecchi A, Bucciarelli P, Cerutti M, et al. Hemostatic abnormalities in Noonan syndrome. Pediatrics. 2014;133(5):e1299\u2013304.","journal-title":"Pediatrics"},{"issue":"8784","key":"2122_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0140-6736(92)90141-O","volume":"339","author":"M Sharland","year":"1992","unstructured":"Sharland M, Patton MA, Talbot S, Chitolie A, Bevan DH. Coagulation-factor deficiencies and abnormal bleeding in Noonan\u2019s syndrome. Lancet. 1992;339(8784):19\u201321.","journal-title":"Lancet"},{"issue":"2","key":"2122_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/pbc.23358","volume":"58","author":"BJ Briggs","year":"2012","unstructured":"Briggs BJ, Dickerman JD. Bleeding disorders in Noonan syndrome. Pediatr Blood Cancer. 2012;58(2):167\u201372.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2122_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0022-3476(83)80525-3","volume":"102","author":"CS Kitchens","year":"1983","unstructured":"Kitchens CS, Alexander JA. Partial deficiency of coagulation factor XI as a newly recognized feature of Noonan syndrome. J Pediatr. 1983;102(2):224\u20137.","journal-title":"J Pediatr"},{"issue":"1","key":"2122_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1590\/S0041-87812003000100002","volume":"58","author":"DR Bertola","year":"2003","unstructured":"Bertola DR, Carneiro JD, D\u2019Amico EA, Kim CA, Albano LM, Sugayama SM, et al. Hematological findings in Noonan syndrome. Rev Hosp Clin Fac Med Sao Paulo. 2003;58(1):5\u20138.","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"issue":"2","key":"2122_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/ajmg.1320290205","volume":"29","author":"M De Haan","year":"1988","unstructured":"De Haan M, vd Kamp JJ, Bri\u00ebt E, Dubbeldam J. Noonan syndrome: partial factor XI deficiency. Am J Med Genet. 1988;29(2):277\u201382.","journal-title":"Am J Med Genet"},{"issue":"10","key":"2122_CR16","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1651-2227.1996.tb18225.x","volume":"85","author":"AA Massarano","year":"1996","unstructured":"Massarano AA, Wood A, Tait RC, Stevens R, Super M. Noonan syndrome: coagulation and clinical aspects. Acta Paediatr. 1996;85(10):1181\u20135.","journal-title":"Acta Paediatr"},{"issue":"5","key":"2122_CR17","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/j.thromres.2012.08.314","volume":"130","author":"G Wiegand","year":"2012","unstructured":"Wiegand G, Hofbeck M, Zenker M, Budde U, Rauch R. Bleeding diathesis in Noonan syndrome: is acquired von Willebrand syndrome the clue? Thromb Res. 2012;130(5):e251\u20134.","journal-title":"Thromb Res"},{"key":"2122_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jpeds.2020.01.048","volume":"220","author":"B Briggs","year":"2020","unstructured":"Briggs B, Savla D, Ramchandar N, Dimmock D, Le D, Thornburg CD. The evaluation of hematologic screening and perioperative management in patients with noonan syndrome: a retrospective chart review. J Pediatr. 2020;220:154-8.e6.","journal-title":"J Pediatr"},{"issue":"2","key":"2122_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/adc.67.2.178","volume":"67","author":"M Sharland","year":"1992","unstructured":"Sharland M, Burch M, McKenna WM, Paton MA. A clinical study of Noonan syndrome. Arch Dis Child. 1992;67(2):178\u201383.","journal-title":"Arch Dis Child"},{"issue":"3","key":"2122_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jpeds.2003.11.032","volume":"144","author":"M Zenker","year":"2004","unstructured":"Zenker M, Buheitel G, Rauch R, Koenig R, Bosse K, Kress W, et al. Genotype-phenotype correlations in Noonan syndrome. J Pediatr. 2004;144(3):368\u201374.","journal-title":"J Pediatr"},{"issue":"10","key":"2122_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ejmg.2015.08.005","volume":"58","author":"M Tajan","year":"2015","unstructured":"Tajan M, de Rocca SA, Valet P, Edouard T, Yart A. SHP2 sails from physiology to pathology. Eur J Med Genet. 2015;58(10):509\u201325.","journal-title":"Eur J Med Genet"},{"issue":"10","key":"2122_CR22","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/jth.12359","volume":"11","author":"YA Senis","year":"2013","unstructured":"Senis YA. Protein-tyrosine phosphatases: a new frontier in platelet signal transduction. J Thromb Haemost. 2013;11(10):1800\u201313.","journal-title":"J Thromb Haemost"},{"issue":"20","key":"2122_CR23","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1182\/blood-2012-08-449272","volume":"121","author":"A Mazharian","year":"2013","unstructured":"Mazharian A, Mori J, Wang YJ, Heising S, Neel BG, Watson SP, et al. Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function. Blood. 2013;121(20):4205\u201320.","journal-title":"Blood"},{"issue":"10","key":"2122_CR24","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1074\/jbc.M513068200","volume":"281","author":"MI Kontaridis","year":"2006","unstructured":"Kontaridis MI, Swanson KD, David FS, Barford D, Neel BG. PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects. J Biol Chem. 2006;281(10):6785\u201392.","journal-title":"J Biol Chem"},{"issue":"25","key":"2122_CR25","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1182\/blood.2019001543","volume":"134","author":"M Bellio","year":"2019","unstructured":"Bellio M, Garcia C, Edouard T, Voisin S, Neel BG, Cabou C, et al. Catalytic dysregulation of SHP2 leading to Noonan syndromes affects platelet signaling and functions. Blood. 2019;134(25):2304\u201317.","journal-title":"Blood"},{"issue":"6","key":"2122_CR26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/hae.12503","volume":"20","author":"M Elbatarny","year":"2014","unstructured":"Elbatarny M, Mollah S, Grabell J, Bae S, Deforest M, Tuttle A, et al. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014;20(6):831\u20135.","journal-title":"Haemophilia"},{"issue":"Suppl 2","key":"2122_CR27","first-page":"321","volume":"76","author":"G Gamba","year":"2011","unstructured":"Gamba G, Marabotto F, Losa L, et al. Co-agulation factor deficiencies and abnormal bleeding in Noonan\u2019s syndrome. Horm Res Paediatr. 2011;76(Suppl 2):321.","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"2122_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/jhg.2015.114","volume":"61","author":"Y Aoki","year":"2016","unstructured":"Aoki Y, Niihori T, Inoue S, Matsubara Y. Recent advances in RASopathies. J Hum Genet. 2016;61(1):33\u20139.","journal-title":"J Hum Genet"},{"issue":"7","key":"2122_CR29","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/MPH.0b013e3181e0d152","volume":"32","author":"P Mehta","year":"2010","unstructured":"Mehta P, Parker RI. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome. J Pediatr Hematol Oncol. 2010;32(7):532\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"Suppl 2","key":"2122_CR30","first-page":"21","volume":"76","author":"M Troiano","year":"2011","unstructured":"Troiano M, Gottlieb S, Rey R, et al. Noonan Syndrome: assessment of bleeding disorders. Horm Res Paediatr. 2011;76(Suppl 2):21.","journal-title":"Horm Res Paediatr"},{"issue":"9863","key":"2122_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","volume":"381","author":"AE Roberts","year":"2013","unstructured":"Roberts AE, Allanson JE, Tartaglia M, Gelb BD. Noonan syndrome. Lancet. 2013;381(9863):333\u201342.","journal-title":"Lancet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02122-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-02122-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02122-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T12:10:48Z","timestamp":1638447048000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02122-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2122"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-02122-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"19 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible Institutional Committee on Human Experimentation and with the Helsinki Declaration of 1975 (revised in 2000).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was written by the parents of our patient to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"499"}}